Lifecore Biomedical, Inc. (LFCR)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$5.13
+0.98%
Mkt Cap $261.51M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $33.13M | $35.15M | +6.10% | -$0.27 | -$0.16 | +40.74% | — | — |
| Q4 2025 Nov 6, 2025 | $26.47M | $31.11M | +17.51% | -$0.30 | -$0.29 | +3.33% | — | — |
| Q3 2025 Aug 7, 2025 | $25.25M | $36.44M | +44.33% | -$0.09 | -$0.10 | -11.11% | — | — |
| Q2 2025 Apr 3, 2025 | $35.36M | $35.15M | -0.59% | -$0.14 | -$0.19 | -35.71% | — | — |
| Q1 2025 Jan 2, 2025 | $33.23M | $32.56M | -2.00% | -$0.27 | -$0.25 | +7.41% | — | — |
| Q3 2024 Aug 26, 2024 | $29.75M | $24.70M | -16.95% | -$0.12 | -$0.15 | -25.00% | — | — |
| Q3 2024 Aug 9, 2024 | $29.75M | $37.89M | +27.35% | -$0.12 | -$0.41 | -241.67% | — | — |
| Q2 2024 May 22, 2024 | $24.42M | $35.70M | +46.21% | -$0.23 | $0.43 | +285.65% | — | — |
| Q4 2023 Dec 29, 2023 | $24.54M | $30.15M | +22.86% | -$0.23 | $0.39 | +269.74% | — | — |
| Q3 2023 Aug 31, 2023 | $24.54M | $24.52M | -0.07% | -$0.07 | -$0.89 | -1171.43% | — | — |
| Q2 2023 Jun 1, 2023 | $29.02M | $31.55M | +8.70% | -$0.13 | -$0.22 | -69.23% | — | — |
| Q2 2023 May 16, 2023 | $28.00M | $26.54M | -5.23% | -$0.13 | -$0.22 | -69.23% | — | — |
| Q1 2023 Mar 16, 2023 | $46.61M | $21.86M | -53.09% | -$0.04 | -$0.24 | -500.00% | — | — |
| Q4 2022 Oct 6, 2022 | $42.74M | $43.35M | +1.44% | -$0.13 | -$0.32 | -146.15% | — | — |
| Q3 2022 Aug 10, 2022 | $45.86M | $47.63M | +3.86% | -$0.01 | -$0.01 | -25.00% | — | — |
| Q2 2022 Apr 5, 2022 | $48.41M | $53.07M | +9.63% | -$0.01 | -$0.08 | -1500.00% | — | — |
| Q1 2022 Jan 5, 2022 | $131.68M | $129.49M | -1.66% | $0.02 | $0.05 | +225.10% | — | — |
| Q3 2021 Sep 29, 2021 | — | $128.79M | — | -$0.12 | -$0.23 | -91.67% | — | — |
| Q3 2021 Jul 28, 2021 | — | $139.83M | — | $0.01 | $0.07 | +975.27% | — | — |
| Q2 2021 Apr 7, 2021 | — | $137.78M | — | -$0.02 | -$0.09 | -475.08% | — | — |